Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone effects on bone density in type 2 diabetes mellitus
ACTRN12607000610437Phase 4Completed
- Sponsor
- Andrew Grey
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) comparing Pioglitazone with Placebo (2 arms). Primary endpoint: Change in lumbar spine bone density. Started Oct 2008; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ACTRN12607000610437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000610437.